Novo Nordisk A/s

Fujitsu Corporation

Boe Technology Group Co., Ltd.

Fuzhou Boe Optoelectronics Technology Co., Ltd.

Nsfocus Information Technology Co., Ltd.

Beijing Didi Infinity Technology and Development Co., Ltd.

Crsc Research & Design Institute Group Co., Ltd.

Rong Zhou

Henrik Oestergaard

Jianhe Chen

Per J Greisen

Mikkel Nors Harndahl

Haisun Zhu

Jun Sun

Wei Zhou

Prafull S Gandhi

Laust Bruun Johnsen

Morten Groenbech Rasch

Bjarne Gram Hansen

Zhiru Yang

Bo Hu

Lifeng Lin

Anders Svensson

Hailong Wang

Karina Thorn

Bo Qin

Xin Lin

Liuan Wang

Chunyu Li

Jianshu Wang

Huaigu Ou

Pei Hu

Mingfeng Huang

Zhiming Song

Congyu Li

Eva Johansson

Longlong He

Jianhua Niu

Qingyao Meng

Binbin Huang

Lixiong Zhu

An array substrate includes a driving circuit arranged on the base substrate, and the driving circuit includes a pull-up node control circuit, a first pull-down node control circuit, and an output circuit; the pull-up node control circuit controls a potential of the pull-up node; the first pull-down node control circuit controls to write a first control voltage provided by the first control voltage line into the first pull-down node; the output circuit controls the driving signal output terminal to output a driving signal under the control of the potential of the pull-up node; the array substrate also includes a first conductive portion arranged on the base substrate; the first conductive portion is electrically connected to the first control voltage line.

Array substrate, manufacturing method and display device

The present invention relates to improved procoagulant antibodies including bispecific antibodies capable of binding to coagulation Factor IX (FIX) or the activated form thereof Factor IXa (FIXa) and optionally Factor X (FX) and the activated form thereof Factor Xa (FXa) and promoting FX activation by FIXa, antibodies binding their epitopes and methods and composition for treating subjects suffering from a coagulopathy such as haemophilia A.

Procoagulant antibodies

The present invention relates to multispecific procoagulant antibodies capable of binding to coagulation Factor IX (FIX) and/or the activated form thereof Factor IXa (FIXa), and Factor X (FX) and/or the activated form thereof Factor Xa (FXa) and promoting FX activation by FIXa, antibodies binding their epitopes or parts thereof and methods and composition for treating subjects suffering from a coagulopathy such as haemophilia A as well as kits, methods of manufacture and methods of use.

A device and a method for electromagnetic field simulation are provided. The image processing device is to obtain, with a first resolution, a first electromagnetic field simulation result of a simulation region, and to derive a second electromagnetic field simulation result with a second resolution, according to the first electromagnetic field simulation result, using a model trained based on a deep learning method. The second resolution is higher than the first resolution.

Device and method for electromagnetic field simulation

A method, device and system for network security protection comprise: according to a received scan task, a network security device performs a security bug scan of the scan task appointed web site, and when a scan result is obtained, transmits the scan result to a network application firewall, so that the network application firewall can configure a individuality security strategy for the web site according to the received scan result. The problem that it can not he implemented complete individuality security configuration of the web site can be solved in this way.

Web security protection method, device and system

Growing community of inventors

Beijing, China

Rong Zhou